8th National Cancer Institute Directors meeting, Lyon, 10-12 July, 2013
The eighth meeting of National Cancer Institute Directors will take place in Lyon between 10th and 12th July, 2013. As requested by participants, the focus on cancer care will continue to increase with the sharing of experience in a wide variety of resource settings underlined. Highlights this year will include: the launch of State of… More
iPRI Welcomes Mark Clanton
The International Prevention Research Institute is proud to welcome a new iPRI Senior Research Fellow, Dr. Mark Clanton. In 2006, Mark Clanton served as the principal Deputy Director of the National Cancer Institute, National Institute of Health, under NCI Director Andrew von Eschenbach. His duties included providing senior executive oversight of the NCI Cancer Center… More
Alcohol: Science, Policy, and Public Health published
Oxford University Press has just published the milestone book: ‘Alcohol: Science, Policy, and Public Health’. This is the second in the series following ‘Tobacco: Science, Policy and Public Health’, now in its second edition. The publication brings together scientific knowledge and public health policy in order to address the increasing important issues of alcohol use and abuse. It was… More
Phillipe Autier receives certificate of excellence
The European Journal of Cancer has granted Dr Philippe Autier, Vice-President Population Research at iPRI, a certificate of excellence in reviewing in recognition of his outstanding contribution to the quality of the journal. We congratulate Dr Philippe Autier for this recognition. iPRI is committed to defending and furthering the quality of science.… More
World Breast Cancer Report launched
Washington DC, World Cancer Day, 4 February 2013 – Today, the 2012 World Breast Cancer Report was officially launched at the Global Women’s Cancer Summit. The 600-page report was authored by experts from a wide range of countries on all continents. Breast cancer has been known and written about for millennia and has been the… More
Publication of p53 book
iPRI is pleased to announce the publication of the book “p53 in the Clinics”, co-edited by Pierre Hainaut, Research Director in iPRI, Magali Olivier, IARC, and Klas G. Wiman, Karolinska Institutet. This book follows the success of 25 Years of p53 Research and condensates in a series of authoritative chapters the considerable progress on the applications… More
Review of the first iPRI textbook
A review of the first “iPRI Scientific Publication”, Textbook on Epidemiology and Biostatistics, has been published in the American Journal of Epidemiology on September 18th, 2012. Click here to read the review: Am J Epidemiol. 2012;176(7):656–657.… More
Prof. Boyle, honorary Doctor of Laws
The University of Dundee has honoured leading figures from Scotland and the world at its summer Graduations in June 2012. Peter Boyle was honoured to be awarded the degree of Doctor of Laws honoris causa in recognition of his contribution to Global Public Health. Professor Pete Downes, Principal of the University of Dundee, said, ”Our Honorary… More
Dr. Greco joins iPRI
iPRI is delighted to announce that Dr Donato Greco joins as Senior Research Fellow. He has founded and later directed the National Centre for Epidemiology of the National Institute of Health of Italy, where he served for 32 years. Donato Greco was born in Naples, Italy, and graduated in medicine with a specialisation in infectious diseases,… More
One more award for Prof. Leigh
It is with great pleasure that we announce that Professor Irene May Leigh, an iPRI Senior Research Fellow, has been awarded the Sir Archibald Gray Medal by the British Association of Dermatologists. This acknowledges her outstanding contribution to Dermatology. We all join in congratulating Professor Leigh on this recognition of her outstanding career and contribution… More
Prof. Leigh awarded
It is with great pleasure that we announce that Professor Irene May Leigh, an iPRI Senior Research Fellow, has been honoured with the award of a CBE (Commander of the Most Excellent Order of the British Empire) in the most recent Queen’s Birthday Honours List. This acknowledges her outstanding contribution to Medicine and follows a previous award… More
New partnership between iPRI and ENVIRON
iPRI President Peter Boyle and ENVIRON CEO Steve Washburn are pleased to announce a collaborative research partnership between the International Prevention Research Institute and international consultancy ENVIRON. ENVIRON’s ability to serve clients in understanding complex human health issues, especially in Europe, will complement iPRI and its global network of epidemiology and public health experts, and… More
Dr. Hainaut, Professor at the University of Malaya
We are delighted to announce that, as of the 4th of June, 2012, Pierre Hainaut was offered an appointment of Visiting Professor at the University of Malaya, in Kuala Lumpur, Malaysia.… More
Today is World No Tobacco Day
Today, Thursday 31 May, is World No Tobacco Day, a day dedicated to highlighting why tobacco is harmful, and why quitting is life-saving. Tobacco remains the single most important preventable cause of chronic disease on a global scale. While in high-income countries the fight against tobacco is increasingly successful, the epidemic of use of smoking… More
iPRI welcomes Dr. Temple Smith
iPRI is delighted to announce that Dr. Temple Smith joins as Senior Research Fellow. He is a Professor in the Departments of Biomedical Engineering and Pharmacology at the Boston University. Temple Smith graduated with a Ph.D. in Nuclear Physics from University of Colorado. He did a joint postdoctoral fellowship under the direction of the mathematician, Stanislaw… More
Burden of sunbed use in France
A new study conducted by iPRI, and published the 23thof May in the Bulletin d’Epidemiologie Hebdomadaire, evaluates the impact of sunbed use on the incidence of cutaneous melanoma in France. With 13.4% of users in France, as reported by the Baromètre Cancer 2010 of the INPES, sunbed is estimated to cause 347 melanoma cases each… More
The 7th NCID meeting in Lyon
The seventh meeting of National Cancer Institute Directors will take place in Lyon between 11th and 13th July, 2012. The previous meeting attracted 85 participants from 45 countries at varying levels of income and resource. The 2012 meeting has already attracted a great deal of interest and several projects initiated at our last meeting have… More
EU and US biological and medical sciences cooperation
On the initiative of Seán Kelly, Member of the European Parliament, a series of biomedical sciences cooperation seminars will be held in Washington DC. These meetings aim to encourage further dialogue on international Science Interaction between members of the US Congress, officials from EU Institutions, and leading international scientists as well as their industry partners… More
Dr. Hainaut joins iPRI
It is with great pleasure that we welcome Dr. Pierre Hainaut to iPRI. Pierre Hainaut was born and educated in Belgium. He obtained an Msc in Science in 1980 and a PhD in Biological Sciences in 1987 from the University of Liège. From 1987 to 1994, he has been held postdoctoral positions in France (INSERM)… More
Mr. Michael P. Johnson
It is with great sadness that we announce that Michael P. Johnson passed away today after battling a long illness. Mike was an outstanding finance officer and administrator who had a long and successful career with the World Health Organisation. He was a stickler for following the rules of the organisation and contributed immensely to… More
News Releases
8th National Cancer Institute Directors meeting, Lyon, 10-12 July, 2013
The eighth meeting of National Cancer Institute Directors will take place in Lyon between 10th and 12th July, 2013. As requested by participants, the focus on cancer care will continue to increase with the sharing of experience in a wide variety of resource settings underlined. Highlights this year will include: the launch of State of Oncology Report and State of Oncology in China Report; presentation of The Global Fund to Fight Aids, Tuberculosis and Malaria; a discussion of how to treat women with breast cancer and diabetes; a roundtable on the Value of Cancer Care for Society; presentation of current status and issues in population screening in high-income and low-income countries; the Strathclyde Institute for Global Public Health at iPRI and discussion of the need to reassess outcomes in clinical trials of cancer therapy.
A limited number of attendees could still be accommodated. Further details can be obtained by contacting the secretariat at ncid2013@i-pri.org.
Institute of Global Public Health established in Lyon and Glasgow
NEWS RELEASE Glasgow, Scotland (UK) / Lyon, France, 12 December 2012 — The University of Strathclyde has today signed a Memorandum of Understanding with the International Prevention Research Institute to establish the Institute of Global Public Health. The new Institute will be based in Glasgow and Lyon and have the objective of developing novel, collaborative… Continue Reading
ESMO 2012
New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe have been presented during the ESMO 2012 Congress of the European Society for Medical Oncology, in Vienna. “Here we have two studies of enormous importance,” noted Prof Peter Boyle, President of the International Prevention… Continue Reading